Lau Associates’s Celgene Corp CELG Stock Holding History

Lau Associates’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,500	Closed	-$224K	–	104
2018 Q4	$224K	Buy	3,500 +400	+13%	+$29.5K	0.12%	92
2018 Q3	$277K	Buy	+3,100	New	+$274K	0.16%	80

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lau Associates's CELG Position: Q1 2019 in Review

Lau Associates sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 3,500 shares — an estimated $224K sold.

Lau Associates first reported a position in CELG in Q3 2018 and held it in 2 quarters. The position peaked at $277K in Q3 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

Lau Associates reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
Lau Associates sold 3,500 Celgene Corp shares in Q1 2019, an estimated $224K.
Lau Associates first reported a position in Celgene Corp in Q3 2018 and held it in 2 quarters.
Lau Associates's Celgene Corp position peaked at $277K in Q3 2018.
1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Lau Associates's 13F filing for Q1 2019, filed 6 May 2019.